AI Model IDs Patients to Best Benefit from ADT for Prostate Cancer Treatment
The AI-based predictive model was able to identify patients with a predominantly intermediate risk for prostate cancer likely to benefit from short-term ADT.
Read MorePosted by Melanie Hamilton-Basich | Jul 7, 2023 | Prostate |
The AI-based predictive model was able to identify patients with a predominantly intermediate risk for prostate cancer likely to benefit from short-term ADT.
Read MorePosted by Melanie Hamilton-Basich | Jun 9, 2023 | Prostate |
American Indian and Alaska Native men also experience disproportionately greater prostate cancer mortality compared to other racial/ethnic identities.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Prostate |
The accuracy of PSA in prostate cancer screening can be improved by accounting for genetic factors that are not associated with cancer.
Read MorePosted by Chris Wolski | May 18, 2023 | Prostate |
Levels of PSA are low in healthy men but elevate in the presence of prostate cancer and other mentioned conditions.
Read MorePosted by Melanie Hamilton-Basich | Apr 26, 2023 | Prostate |
A new minimally invasive prostate biopsy procedure reduces the risk of infection, improves imaging for accuracy, and may increase cancer detection in a clinic setting.
Read More